Let’s Talk About Cybersecurity: US FDA Wants Feedback On Safety Alerts
Executive Summary
The FDA is convening a panel of experts in September to talk about how to craft cybersecurity communications that adequately alert patients about potential vulnerabilities while not creating a panic. The meeting comes as the agency has been putting out a growing number of cybersecurity alerts, including most recently a recall for certain vulnerable Medtronic insulin pumps.
You may also be interested in...
FDA: Keep Cybersecurity Vulnerabilities Messaging Short And Simple
The US agency published a paper that’s based on recommendations from experts and other stakeholders on how to best let patients know their device may be vulnerable to a cybersecurity attack.
Cybersecurity: Guidance Docs To Come, But Legacy Devices Still A Challenge
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Lack Of Funding Stalls Major US FDA Cybersecurity Initiative
A public-private partnership board long touted by top US FDA officials to help address cybersecurity threats has hit a funding wall. The agency received less than half of what it asked for in the FY 2019 budget for its digital efforts, including its cybersecurity strategy, leading it to make some tough choices.